Hiroto Takada
Aomori, 0381331, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Plasma Neurofilament Light Chain and Phosphorylated Tau Are Elevated in Myotonic Dystrophy Type 1.
Journal: Journal of clinical medicine
Published: September 14, 2025
Investigation of Glucose Metabolism by Continuous Glucose Monitoring and Validation of Dipeptidyl Peptidase 4 Inhibitor Use in Patients with Myotonic Dystrophy Type 1.
Journal: Journal of clinical medicine
Published: July 30, 2024
Facioscapulohumeral muscular dystrophy Health Index: Japanese translation and validation study.
Journal: Disability and rehabilitation
Published: March 31, 2024
CTG repeat length underlying cardiac events and sudden death in myotonic dystrophy type 1.
Journal: European heart journal open
Published: March 25, 2024
Natural history of Becker muscular dystrophy: a multicenter study of 225 patients.
Journal: Annals of clinical and translational neurology
Published: September 21, 2023
The current status of medical care for myotonic dystrophy type 1 in the national registry of Japan.
Journal: Muscle & nerve
Published: July 27, 2022
Safety and immunogenicity of mRNA COVID-19 vaccine in inpatients with muscular dystrophy.
Journal: Muscle & nerve
Published: April 19, 2022
Quality of life and subjective symptom impact in Japanese patients with myotonic dystrophy type 1.
Journal: BMC neurology
Published: July 16, 2021
Characteristics of myotonic dystrophy patients in the national registry of Japan.
Journal: Journal of the neurological sciences
Published: March 18, 2021
Cerebral ventriculomegaly in myotonic dystrophy type 1: normal pressure hydrocephalus-like appearances on magnetic resonance imaging.
Journal: BMC neuroscience
Published: January 10, 2021
Metabolic complications in myotonic dystrophy type 1: A cross-sectional survey using the National Registry of Japan.
Journal: Journal of the neurological sciences
Published: December 14, 2020
Last Updated: 09/26/2026